Zanubrutinib in Primary Cold Agglutinin Disease
Zanubrutinib in Primary Cold Agglutinin Disease
Active, not recruiting · NCT06067048 · Registry updated 2026-03-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanubrutinib in Primary Cold Agglutinin Disease | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-03-06 | NCT06067048 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 27 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdan UMC ( location AMC) | Amsterdam | Netherlands | 1 |
| AZ Delta | Roeselare | Belgium | 25 |
| Erasusmc | Rotterdam | Netherlands | 1 |
| Haukeland University Hospital Bergen | Bergen | Norway | 1 |
| Odense University Hospital | Odense | Denmark | 57 |
| Oslo University Hospital | Oslo | Norway | 111 |
| Rigshospitalet | Copenhagen | Denmark | 84 |
| St. Olavs hospital | Trondheim | Norway | 17 |
| UMCG | Groningen | Netherlands | 20 |
| UZ Leuven | Leuven | Belgium | 82 |